Almac Pharma Services Expands it Commercial Support Capability
March 20, 2008
Due to increasing demand for commercial support services in Europe from non-EU based manufacturers, Almac Pharma Services has completed a series of investments that will strengthen its capabilities in a growing service area.
As new projects have been secured, the company has expanded its modular refrigerated rand frozen storage facilities, enabling it to take more temperature sensitive drug products into its commercial portfolio.
The company’s ability to offer custom storage, labeling, packing and distribution services from brite stock inventories has also been enhanced through the acquisition of additional bespoke vial/ampoule labeling equipment.
Complementing this expanded capability, the company is at late stage development of an e-portal that will improve material handling at all stages of the supply chain and offer clients, secure, online access to vital supply data thus improving decision-making and service levels.
Almac Pharma Services’ President & M.D, Graeme McBurney commented, “These investments add to the already significant “single site” service advantages available within the company.” He said, “Reliable and experienced providers of all these services are very difficult to secure, yet the services are vital to every successful product launch in Europe by niche and speciality Pharma companies”.
About Almac Pharma Services
Almac Pharma Services, a division of the Almac Group, is an FDA and EU approved outsourcing partner to the global pharmaceutical and biotechnology industries. We have over 30 years’ experience in the development and manufacture of solid, oral dosage products. Our capabilities include formulation and analytical development, clinical and commercial-scale drug product manufacture, primary and secondary packaging and global supply chain management.
About Almac Group
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS/Web/EDC), to commercial-scale manufacture. Almac provides services to more than 600 companies, including world leaders in the pharmaceutical and biotech sectors. The company has 2,000 employees and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. For more information about the Almac Group, please visit www.almacgroup.com.
T: +1 (610) 666 9500 (US) & +44 (0)28 3833 2200 (Europe)